Following human burn injury, AMPs are reduced or absent from acute burn wounds and blister fluid compared with nonburn wounds. 22, 23 In other studies of acute burn wounds, changes in the localization of AMPs were observed in the remaining keratin layers and in surviving dermal and subcutaneous layers, including hair follicles and sweat glands, but not in vascular endothelium or adipocytes. 24, 25 Previous studies in human acutely burned skin and burn blister fluid revealed significant hBD decrease compared with unburned subjects. [22] [23] [24] Furthermore, previous studies in mice and humans have demonstrated that burn-induced myeloid cells are capable of suppressing keratinocyte AMP production. 26, 27 In contrast to AMPs, few studies have attempted to characterize the effects of burn injury on lipid composition in surrounding tissue (burn margin) or distal skin (potential donor site). Using an established acute scald-burn mouse model, we recently determined that the epidermal antimicrobial and lipid barrier function at both the burn margin and the potential donor site is compromised compared with skin from unburned mice, leading to greater water loss from the skin and delayed barrier recovery. 28 Similar to the burn margin, distal unburned skin from burned mice displayed greater cutaneous protease activity and altered AMP production, which paralleled a diminished ability to inhibit the growth of several skin microbes. 28 This suggests that the compromised epidermal barrier from donor skin in human burn subjects may contribute to graft failure, wound infection, sepsis, or other infectious complications. Furthermore, dysregulation of AMPs and lipids following burn injury likely alters the cutaneous microbiome at potential donor sites, as bacteria that comprise the skin microbiota likely stimulate or are influenced by AMPs, lipids, and other innate immune molecules. 29, 30 In this study, we investigate the impact of burn injury on epidermal lipid regulation and AMP responses in human donor skin and burn margin, to identify potential mechanisms that may lead to graft failure and/or impaired burn wound healing.
Materials and Methods

Sample Collection
All protocols were approved by the institutional review board at Loyola University Chicago, Health Sciences Campus. A standing approval for discarded skin was used to collect the tissue samples. Burn patients admitted to the burn intensive care unit (BICU) with the following were excluded from the study: age < 18 years, pre-existing clinically evident infection, pre-existing skin disease (ie, eczema, psoriasis, rosacea, etc), previous transplant recipient, recent major traumatic injury (ie, broken bones, fall, surgery, etc.) <4 months before the burn injury, pre-existing immunodeficiency, and/or a history of disseminated cancer. The following clinical characteristics and outcomes were obtained from the electronic medical records and entered into a database: age, sex, %TBSA injured, inhalation injury, burn injury mechanism, sepsis and/or multisystem organ dysfunction, pneumonia, urinary tract infection, graft failure, wound infection, and mortality. Injury severity was determined based on %TBSA with partial and/or full thickness burns, which was recorded in the patient's medical records. Per the BICU standard protocol, initial fluid resuscitation was conducted according to the Parkland formula (4 ml/kg/% TBSA with half given during the first 8 hours following injury and the remaining half given during the next 16 hours). Discarded skin samples from burn patients undergoing routine excision/ e214 Plichta et al January/February 2017 debridement and skin grafting were collected in the operating room. The burn margin (partial thickness) was taken from the skin adjacent to the excised area of the burn and not directly in contact with the thermal source. When the burn wounds were excised, a 5 to 10 mm margin of grossly normal appearing skin was excised simultaneously with the wound. The wound itself was debrided to viable tissue to allow for optimal wound healing in the patients, thus yielding viable tissue at the burn margin that was excised. Donor skin (partial thickness) was taken from a site distal to the original injury (autograft site), per standard surgical protocols. Although the same burn patient may have had multiple surgeries and thus contributed multiple samples to the study, none of the patients required repeat use of a specific donor site. Control skin samples were collected in the operating room from patients undergoing nononcologic, elective surgeries (such as breast reduction or panniculectomy). Skin samples were either snap-frozen in liquid nitrogen, placed in Trizol ® (Life Technologies, Woburn, MA), embedded in optimal cutting temperature (OCT; TissueTek ® O.C.T.™ Compound, Radnor, PA), or placed in acetic acid, and were stored appropriately before tissue processing. For the subsequent experiments described, the N for each group was variable due to the amount of sample obtained at the operation, and thus, it was not feasible to use every sample for every assay. Subgroups of the patient samples were utilized at the time of each assay performance and were randomly selected for individual assays while quantities were available.
Enzyme-Linked Immunosorbent Assay
Enzyme-linked immunosorbent assay (ELISA) was performed for interleukin (IL)-6, IL-8, hBD1, hBD2 (PeproTech, Rocky Hill, NJ), s100A7 (CircuLex), RNASE7 (CUSABIO, College Park, MD), and LL37 (Hycult Biotech, Plymouth Meeting, PA) according to each manufacturer's protocol. Protein concentrations of skin homogenates were determined using a bicinchoninic acid assay kit (Thermo Scientific). The ELISA results were then normalized to total protein concentrations. These analyses were performed in duplicate.
Quantitative Polymerase Chain Reaction
Skin samples were homogenized directly in Trizol (Life Technologies, Carlsbad, CA), and RNA was extracted per the manufacturer's instructions. RNA was reverse transcribed using iScript (Bio-Rad, Hercules, CA) according to the manufacturer's protocol. cDNA samples were analyzed to detect the expression of acetyl-CoA carboxylase alpha (ACC, Hs01046047_m1), fatty acid synthase (FAS, Hs01005622_m1), hydroxymethylglutaryl-CoA reductase (HMGCR, Hs00168352_m1), serine palmitoyl transferase (SPTLC1, Hs00272311_m1), β-defensin 1 (DEFB1, Hs00608345_m1), β-defensin 4a (DEFB4A, Hs00175474_m1), cathelicidin antimicrobial peptide (CAMP, Hs00189038_ m1), ribonuclease 7 (RNASE7, Hs00261482_m1), psoriasin (s100A7, Hs00161488_m1), kallikrein-5 (klk5, Hs01548153_m1), kallikrein-7 (klk7, Hs00192503_m1), IL-6 (Hs00985639_m1), IL-8 (Hs00174103_m1), and IL-22 receptor (IL-22R, Hs00364814_m1). Quantitative real-time polymerase chain reaction was performed using the TaqMan Gene Expression pre-mix (Life Technologies, Carlsbad, CA) and Applied Biosystems 7000 Sequence Detection System (Foster City, CA). To normalize the mRNA expression levels, the relative expression of β-2-microglobulin (B2M, Hs99999907_m1) was analyzed in parallel. Results were analyzed using the 2 (−∆∆Ct) method. Foldchange relative to the control group was calculated (default level set at 1). Each sample from each cohort was analyzed in duplicate.
Lipid Staining and Immunohistochemistry
Nile red staining was performed as previously described to assess epidermal lipids. 28 In brief, skin was embedded in OCT compound, stored at −80°C, and subsequently sectioned to 8 μm samples using a cryostat. For Nile red staining, tissue sections were expanded using half-strength Sorensen-Walbum buffer for 20 minutes. A stock solution containing 0.05% (wt/vol) Nile red in acetone was stored at 4°C, protected from light. Before staining, the stock solution was diluted to 2.5 μg/ml with 75:25 (vol/vol) glycerol:water and briskly vortexed. A single drop of the glycerol-dye solution was applied to each tissue section and immediately covered with a coverslip. Samples were protected from light and incubated at 37°C for 1 hour. Sections were examined with an Evos Digital Microscope using a 20× objective. These analyses were performed in duplicate.
Immunohistochemistry was performed on the skin using primary antibodies for KLK5 (R&D Systems), KLK7 (R&D Systems), and appropriate secondary antibodies as previously described. 28 In brief, tissue samples were embedded in OCT and sectioned at 8 μm using a cryostat. Sections were fixed in acetone, incubated in blocking buffer, then incubated overnight at 4°C with the appropriate dilution of primary antibody in blocking buffer. The following day, sections were washed and incubated at room temperature with the appropriate secondary antibody conjugated to Cy3 or Alexa-fluor 456. Nuclei were stained using ProLong ® Antifade Gold with DAPI (Life Technologies, Carlsbad, CA). Images were obtained with an Evos Digital Inverted Microscope using a 20× objective and analyzed in a blinded manner. These analyses were performed in duplicate.
Quantitative and Qualitative Protease Assay
Protein extraction was done by homogenizing skin and filtering the supernatant. The protein concentrations of the samples were then analyzed using a standard bicinchoninic acid protein assay (Thermo Scientific Pierce, Waltham, MA). Protease activity was assessed using the EnzChek Protease Assay kit (E6638 green fluorescence, Molecular Probes Inc, Life Technologies, Carlsbad, CA), according to the manufacturer's instructions and as previously described. 17, 28, 31 In brief, quantitative measurements were assessed on whole protein extracts from homogenized skin samples. Trypsin (Life Technologies, Carlsbad, CA) with and without the protease inhibitor Dispase II (Roche, Indianapolis, IN) were used as controls. Protease activity was measured using pH-insensitive green fluorescent BODIPY-FL-conjugated casein as a substrate in a total reaction volume of 200 µl. All enzymes and extracts were diluted in PBS (pH 7.4). After the addition of 100 µl of substrate solution and 100 µl (up to 10 µg) of sample into 96-well plates, the reaction mixtures were incubated for 24 hours at room temperature while protected from light. Fluorescence was measured using a Synergy 2 microplate reader (BioTek Instruments, Winooski, VT) at an excitation wavelength of 485 nm and an emission wavelength of 530 nm using the Gen 5 program. These analyses were performed in duplicate.
Qualitative protease activity was assessed on sectioned skin samples prepared in OCT (8 μm sections), as previously described. 28 In brief, skin sections were washed and incubated with the BODIPY-FL-conjugated casein substrate from the EnzChek Protease Assay kit (E6638 green fluorescence, Molecular Probes Inc, Life Technologies, Carlsbad, CA) at a concentration of 2 μg/ml for 1 hour at 37°C, protected from light. Slides were again washed, and the nuclei were stained using ProLong ® Antifade Gold with DAPI (Life Technologies, Carlsbad, CA). Sections were examined with an Evos Digital Microscope using a 20× objective. All samples were analyzed in a blinded manner, and all experiments were performed in duplicate.
High Pressure Liquid Chromatography Purification of Skin Extracts
Skin samples were placed in 1N acetic acid for at least 24 hours at 4°C, homogenized, lyophilized, and then dissolved in water. High pressure liquid chromatography peptide separation was performed using a C18 column (8 μM, ST 4.6/250; Thermo Scientific #25008-254630). Equilibration was done in 0.1% trifluoroacetic acid. Peptides were eluted with an acetonitrile gradient (10-100% over 40 minutes at 2 ml/ min with fractions collected from 10-30 minutes). 32 All fractions (2 ml each) were lyophilized and reconstituted in 50 μl of sterile water, and then combined into one sample (all fractions from one patient were combined into a single sample). Combined samples were again lyophilized and resuspended in 20 μl of sterile water. Samples were then normalized for peptide content, as determined by an OD reading at 214 nm.
Antimicrobial Radial Diffusion Assay
Recombined high pressure liquid chromatography fractions were evaluated using a radial diffusion assay, as previously described. 28, 29 Antimicrobial activity was assessed against Escherichia coli (E. coli, ATCC), Pseudomonas aeruginosa (P. aeruginosa, clinical isolate), Staphylococcus aureus (S. aureus; strain SA113; ATCC), and Group A Streptococcus (GAS; M49 strain, NZ141). Bacteria from glycerol stocks were inoculated and grown in tryptic soy broth, Todd Hewitt broth, or Luria broth at 37°C overnight, as appropriate. The overnight cultures were then diluted 1:100 and grown to the exponential phase. Thin plates (1 mm) with 1% SeaKem ® GTG ® Agarose (Cambrex Corporation, East Rutherford, NJ) in 0.5% tryptone containing ~4 × 10 5 cells/ml of bacteria were used for the assay. Sterile water and synthetic catestatin (100 μM, GeneScript) were used as the negative and positive controls, respectively. The zone of inhibition of bacterial growth (area) was quantified using ImageJ Software (National Institutes of Health, Bethesda, MD). Samples were used to perform these experiments in duplicate.
Statistical Analysis
All quantitative data are described as mean ± standard error of the mean. Comparisons between control vs margin and control vs donor were performed using a Mann-Whitney test for all human samples. P values ≤.05 were considered statistically significant. We did not use a one-way analysis of variance, as we were not comparing donor vs margin. For analysis of the in vitro model data, a two-way analysis of variance with a Bonferroni post test was used. A P value ≤.05 was considered statistically significant. Data analyses 
results
Clinical Assessment and Patient Demographics
Samples from 43 patients admitted to the BICU were evaluated in this study. Patients used for the analysis had characteristics that are representative of the general population treated in the BICU ( Table 1) . Ages of the patients ranged from 20 to 87 years (mean of 47, median of 46), burn sizes ranged from 1 to 52% TBSA (mean of 18%, median of 12.5%). On average, the burn skin samples were collected during routine surgeries (excision, debridement, and grafting) within 5 days post burn (details provided in Table 2 ). Of the 43 patients studied, 28% (n = 12 patients) developed pneumonia, 42% (n = 18 patients) suffered a wound infection of the donor or burn site, and 25% (n = 11 patients) were treated for blood culture positive sepsis. Even with the high rate of complications seen in our study group, only five patients (11%) succumbed to their illness. The control samples were taken from healthy patients with no chronic diseases or skin disorders, with a mean age of 49 years (Table 1) .
Burn Injury Decreases Epidermal Lipid Production and Lipid Synthesis Enzymes in Donor Skin and Burn Margin
The epidermal permeability barrier relies on the production of extracellular lipids (eg, cholesterol, fatty acids, and ceramides) to minimize water loss, promote transport of electrolytes, and limit penetration of chemicals and pathogenic microorganisms. 12 Thus, we first assessed epidermal lipid production between our cohorts using Nile red staining. We observed a robust decrease in epidermal lipid staining in donor skin and burn margin, relative to controls ( Figure 1A ). We then assessed the gene expression of key epidermal lipid synthesis enzymes: ACC, FAS, HMGCR, and SPTL. 12, 33, 34 Both ACC ( Figure 1B ) and FAS ( Figure 1C ) gene expression were significantly lower in both donor skin (P < .001) and burn margin (P < .05) compared with controls. Although no significant change was observed with HMGCR ( Figure 1D ), SPTL gene expression was significantly lower in both donor skin (P < .001) and burn margin (P < .05) relative to controls.
Burn Injury Selectively Alters AMP Gene Expression and Protein Production in Donor Skin and Burn Margin
Because the lipid and AMP barriers are codependent, 15 we next assessed the gene expression of several candidate AMPs known to play a significant role in epidermal barrier function and microbial defense, and compared their expression in donor skin or burn margin relative to control skin. Both hBD1 (DefB1) and hBD2 (DefB4A) gene expression were significantly elevated in margin specimens (P < .025 and P < .001 respectively) relative to controls ( Figure 2A , B); no change was observed between controls and donor skin. Cathelicidin (CAMP) was not significantly different between cohorts, although there was a fourfold increase in margin samples (P = .06; Figure 2C ). However, psoriasin (S100A7) gene expression was significantly elevated in the margin specimens (P < .001) relative to controls ( Figure 2D ). In contrast to the other candidate AMPs, RNASE7 gene expression was significantly reduced in both donor skin and burn margin relative to controls (P < .025; Figure 2E ).
To next determine whether these changes in gene expression parallel changes in AMP protein production in donor skin or burn margin, we assessed skin AMP protein levels by ELISA. hBD1 protein levels were significantly increased in both donor and margin specimens (P < .001 and P < .025; Figure 3A) ; whereas hBD2 was significantly elevated in burn margin only (P < .025) relative to controls. The donor specimens contained nearly identical levels of hBD2 as controls ( Figure 3B ). In contrast, protein levels of LL-37, the bioactive peptide of CAMP, were significantly reduced in burn margin as compared with controls (P < .005; Figure 3C ). No differences in psoriasin levels were observed relative to controls ( Figure 3D) ; however, RNASE7 protein levels were increased in burn margin by ~50% (P < .05; Figure 3E ).
Cutaneous Antimicrobial Activity Is Altered After Burn Injury
We next evaluated whether burn margin or donor skin exhibits normal AMP activity against several 1, 35 Both donor skin and burn margin exhibited a significant decrease in AMP activity against E. coli growth compared with peptides isolated from control skin (P < .003; Figure 4A ). In contrast, we observed a significant increase in AMP activity against P. aeruginosa (P < .025; Figure 4B ) in burn margin and S. aureus (P < .05; Figure 4C ) in both donor skin and burn margin relative to controls. However, no significant changes in AMP activity against Group A Streptococcus were observed between control and donor skin or burn margin.
Protease Activity in Human Skin Altered by Burn Injury
Proteolytic processing of AMPs into bioactive peptides is critical for their antimicrobial and inflammatory capacity. Two epidermal proteases involved in both AMP processing and epidermal barrier function include Kallikrein-5 (KLK5) and KLK7. 16, 17, 28 Thus, we next evaluated the gene expression, protein abundance, and localization of KLK 5 and 7, as alterations in these proteases may likely elicit skin barrier defects after burn injury. Although no significant changes were observed in KLK5 or KLK7 gene expression ( Figure 5A, B) , we did observe more robust staining of KLK5 and KLK7 in burn margins compared with controls, primarily in the epidermis ( Figure 5C ). No differences were observed between donor skin and control specimens when staining for KLK5 or KLK7. When total protease activity was evaluated, we observed a significant increase in the burn margin samples with the quantitative assessment ( Figure 5D ; P < .001) and a robust increase in epidermal protease activity in donor skin and burn margin by immunohistochemistry ( Figure 5E ) when compared with controls. 
Burn Injury Increases Proinflammatory Cytokine Production at the Donor Site
With evidence of altered AMPs in donor skin and burn margin, we next evaluated the same sites for proinflammatory cytokines induced by AMPs in the skin. 36, 37 We first assessed the gene expression of IL-6 and IL-8, and observed that IL6 expression was only elevated in the margin samples ( Figure 6A ; P < .025), whereas IL8 expression was significantly elevated in both donor and margin relative to controls (P < .025 and P < .001; Figure 6B ). When protein concentrations were evaluated, no changes were seen with IL-6 protein levels ( Figure 6C ). However, we observed a significant elevation of IL-8 in both donor and margin relative to controls ( Figure 6D ; P < .025). Nevertheless, we did not observe any robust changes in inflammatory cell numbers in the donor skin by H&E staining (data not shown). These data suggest that AMP dysregulation may correlate with higher levels of proinflammatory mediators in donor skin and burn margin.
discussion
Graft failure at both the donor site and/or burn site is a persistent challenge related to post burn management. Furthermore, burn wound infection at both the donor site and burn site remain a frequent and serious complication of major burn injury, and are associated with over 50% of all deaths related to burn injury. 1, 35, 38 Despite this fact, no studies have examined potential mechanisms by which burn injury at Gene expression of candidate antimicrobial peptides is altered in donor skin and burn margin. Quantitative polymerase chain reaction analysis of (A) DefB1, (B) DefB4A, (C) CAMP, (D) S100A7, and (E) RNASE7 in donor skin and burn margin specimens relative to control skin. *P < .025, #P < .001 using Mann-Whitney U test, n = 10 controls, 28 donors, 26 margins; plots represent means ± standard error of the mean. CAMP, cathelicidin antimicrobial peptide; DefB1, β-defensin 1; DefB4A, β-defensin 4a; S100A7, psoriasin; RNASE7, ribonuclease 7.
a local site impacts epidermal barrier function at the donor site of human burn subjects. The complex pathophysiology of burn injuries results in various local and systemic effects largely related to the acute inflammatory response, thus affecting several organ systems 39 and here we highlight its systemic effects on the skin as a whole. In this study, we established that epidermal lipid and AMP responses are impaired in both donor skin and burn margin from human burn patients. We further identified an increase in epidermal protease activity and proinflammatory cytokine production in both donor skin and burn margin. These alterations in epidermal barrier function may be a source of graft failure, burn wound infections, and/or subsequent infectious complications in burn patients.
Epidermal lipids are critical for maintaining the permeability barrier, modulating wound healing responses, and antibacterial activity. Despite this fact, few studies have attempted to investigate their role in relation to burn injury outcomes. Using an established mouse model, we recently determined that the burn margin and distal, unburned skin (ie, donor skin) exhibited greater epidermal barrier permeability as indicated by a higher pH, greater transepidermal water loss, and reduced lipid synthesis enzyme Protein expression of candidate antimicrobial peptides is altered in donor skin and burn margin. Enzyme-linked immunosorbent assay analysis of (A) β-defensin 1 (n = 6 controls, 17 donors, 18 margins), (B) β-defensin 4a (n = 6 controls, 17 donors, 18 margins), (C) cathelicidin antimicrobial peptide (n = 13 controls, 19 donors, 19 margins), (D) S100A7 (n = 9 controls, 11 donors, 11 margins), and (E) RNASE7 (n = 10 controls, 11 donors, 14 margins) in donor skin and burn margin specimens relative to control skin. *P < .025 and #P < .001 using Mann-Whitney U test; plots represent means ± standard error of the mean. S100A7, psoriasin; RNASE7, ribonuclease 7.
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January/February 2017 expression up to 96 hours post burn. 28 In this study, we were able to confirm that the robust changes in epidermal lipid production and lipid synthesis enzyme production after burn injury is conserved in both mouse and human models. The dramatic alterations in epidermal lipid regulation reported in our mouse and human burn models set the foundation for future studies designed to elucidate the role of lipids and their regulatory mechanisms in relation to burn wound healing.
Although these changes are often part of the "normal" response to thermal injury and result in acceptable outcomes, it may be possible to further optimize the wounds and donor sites to prevent graft failure and improve wound healing. By enhancing the restoration of epidermal lipid homeostasis, the time required for the skin to regain its fundamental barrier functions may be significantly shortened. Several studies using various wound dressings have attempted to mimic the natural barrier function of the skin and demonstrated with variable success improvements in wound healing, patient experiences, and outcomes. 40 However, the optimal dressing remains a topic of significant controversy, and the identification of novel mechanisms for potential intervention could prove quite beneficial. One potential mechanism for impaired epidermal lipid metabolism is through the peroxisome proliferator-activated receptors (PPAR-α, β/δ, or γ), which are ligand-activated nuclear hormone receptors. All three PPAR subtypes are expressed in mice and humans, and exert variable effects on epidermal barrier repair, sebocyte differentiation/ lipogenesis, and keratinocyte differentiation/proliferation/lipogenesis. 41, 42 Furthermore, a deficiency in epidermal PPAR-β/δ was found to delay skin barrier recovery after tape stripping and increase skin inflammation. 43 The observed increase in proinflammatory cytokines in donor skin and burn margin, in conjunction with our lipid analyses in mouse and human, indicate that burn injury may be influencing PPAR-dependent epidermal lipid regulation to impair barrier function and modulate local inflammation, which warrants further investigation. Because topical lipids have been used for centuries to improve wound healing outcomes, 44 application of natural epidermal lipids (eg, ceramides, fatty acids, and cholesterol) to donor skin before grafting may improve burn wound healing outcomes by improving epidermal barrier function and reducing . KLK protein levels and total protease activity are elevated in donor skin and burn margin. qPCR analysis of (A) KLK5 and (B) KLK7 (n = 10 controls, 28 donors, 27 margins) and immunohistochemistry of (C) KLK5 and KLK7 in donor skin and burn margin specimens relative to control skin, n = 10 each group. D. Quantitative total protease activity by fluorescence analysis (n = 19 controls, 10 donors, 10 margins) and (E) qualitative total protease activity by IHC in donor skin and burn margin specimens relative to control skin, n = 10 each group. White dashed line designates dermal and epidermal junction. #P < .001 using Mann-Whitney U test; plots represent means ± standard error of the mean. KLK, Kallikrein.
e224 Plichta et al January/February 2017 inflammation before the graft is placed, thus grafting a less damaged area of skin. AMPs are gene-encoded peptides that comprise a highly conserved component of the innate immune system, and contribute to direct microbial destruction and tissue repair pathways. 10, 11 Several AMPs are expressed in human skin under inflammatory conditions, including burn injury, and exert detrimental effects on epithelial function if their production is in excess. Increased AMP production likely generates a more inflammatory microenvironment through the production of proinflammatory cytokines (eg, IL-6 and IL-8), which can impede normal wound re-epithelialization and promote an oxidative milieu. In parallel, serum levels of IL-6 and IL-8 increase after burn injury, and higher levels are associated with greater morbidity and mortality. [45] [46] [47] [48] In contrast, reduced AMP production may increase the invasive capacity of pathogenic microbes and slow tissue repair pathways. 10, 11 Previous studies in human burn margin or burn fluid have demonstrated a decrease in hBD levels 23, 25 and changes in keratinocyte localization of AMPs. 24, 49 However, no studies have evaluated AMP production or quantitatively assessed AMP protein levels in potential donor sites. Our observed increase in hBD1, hBD2, and RNAse 7, and parallel decrease in LL-37, in both donor skin and burn margin may be due to differences in the skin microbiome after burn injury. Several skin pathogens are known to induce keratinocyte AMPs and proinflammatory cytokines through activation of toll-like receptors.
14,50-53 Furthermore, resident commensal microbes (eg, Staphylococcus epidermidis, Propionibacterium acnes) can produce their own AMPs, augment the normal production of AMPs via keratinocytes, and help maintain inflammatory homeostasis by limiting excess cytokine release after epidermal injury. [54] [55] [56] Several skin pathologies and nonhealing wounds reveal an imbalance of this microbiota, even in the absence of clinical infection. 30, 57, 58 As such, studies are underway to characterize the skin microbiome in donor skin and burn margin after burn injury.
Certain metabolic and hemodynamic mechanisms, which are disrupted after burn injury, may also contribute to the observed AMP dysregulation. For example, it has been established that a pH gradient exists in human skin. 59 We speculate that the observed increase in pH in mouse donor and margin skin after burn injury 28 can exert several deleterious effects on epidermal barrier function by increasing serine protease activity (ie, KLKs), as observed in our studies, and by promoting an imbalance of electrolytes in both the donor skin and burn margin caused . IL-6 and IL-8 protein levels are elevated in donor skin and burn margin. Quantitative polymerase chain reaction analysis of (A) IL6 and (B) IL8 gene expression (n = 8 controls, 14 donors, 13 margins), and enzyme-linked immunosorbent assay analysis of (A) IL-6 (n = 11 controls, 20 donors, 23 margins) and (B) IL-8 (n = 5 controls, 13 donors, 10 margins) in donor skin and burn margin specimens relative to control skin. *P < .025 and #P < .001 using Mann-Whitney U test; plots represent means ± standard error of the mean. IL, interleukin.
